Organolithium
Search Within Results
1
–
3
of
3
results
1
Medchemexpress LLC Turofexorate isopropyl | 629664-81-9 | 99.8% | C25H24F2N2O3 | 1 ML
Turofexorate isopropyl (FXR-450) is a potent, selective, and orally bioavailable FXR agonist with an EC50 of 4 nM. It is intended for research and analytical applications, and an analytical standard is also available.
- Potent, selective, and orally bioavailable FXR agonist
- Used in autophagy, metabolic disease, and cancer research
- Consistent with structure via 1H NMR and MS
- High purity of 99.8%
2
Medchemexpress LLC Turofexorate isopropyl | 629664-81-9 | 99.8% | C25H24F2N2O3 | 50 MG
Turofexorate isopropyl, also known as FXR-450, is a potent, selective, and orally bioavailable FXR agonist. It exhibits an EC50 of 4 nM and is stable under recommended storage conditions. This product is suitable for various laboratory and research applications, particularly in studies related to metabolic disease and cancer.
- Potent, selective, and orally bioavailable FXR agonist
- Features an EC50 of 4 nM
- Stable under recommended storage conditions
- High purity of 99.77% as determined by HPLC
- Consistent with structure based on ¹H NMR spectrum and MS data
- Applicable in metabolic disease and cancer research
3
Medchemexpress LLC Turofexorate isopropyl | 629664-81-9 | 99.8% | C25H24F2N2O3 | 25 MG
Turofexorate isopropyl is a highly potent, selective, and orally bioavailable agonist of the Farnesoid X Receptor (FXR).
- Acts as an agonist for the Farnesoid X Receptor (FXR).
- Exhibits significant potency with an EC50 of 4 nM.
- Characterized by its selective action on FXR.
- Orally bioavailable, making it suitable for certain research applications.
- Utilized in research contexts related to Autophagy, Metabolic Disease, and Cancer.
- Primarily intended for research and analytical applications.